| 中文名称 | GAB氧杂DOL盐酸盐 |
| 英文名称 | GABOXADOL HYDROCHLORIDE |
| CAS号 | 85118-33-8 |
| 分子式 | C6H9ClN2O2 |
| 分子量 | 176.6 |
| EINECS号 | 285-687-7 |
| 熔点 | 236 °C |
| 溶解度 | 在乙醇中的溶解度为0.91mg/mL |
| 形态 | 固体 |
| 颜色 | 白色 |
| 默克索引编号 | 14,4321 |
| 安全说明 | 22-24/25 |
| WGK Germany | 3 |
| RTECS号 | NY3396800 |
| 海关编码 | 2934.99.9001 |
GABA A receptor; GABA C receptor
Gaboxadol hydrochloride (0.34, 3.5 and 7.0 μM) decreses permeability across Caco-2 cell monolayers with a dose dependent manner, shows the mean P app values with 8.1 × 10 -6 cm·s -1 , 6.1 × 10 -1 cm·s -6 and 5.6 × 10 -6 cm·s -1 for 0.34, 3.5 and 7 μM gaboxadol, respectively.
Gaboxadol hydrochloride (intraperitoneal injection; 0.5, 1, 1.5, 2, 3, 4, or 5 mg/kg; once daily; three-day interval) normalizes the distance traveled by Fmr1 KO2 mice to WT activity levels at 0.5 mg/kg, additionally, this compound has no effect on locomotor activity in Fmr1 KO2 mice.
| Animal Model: | Fmr1 KO2 mice (deletion of the promoter and first exon of Fmr1 resulting in mRNA and protein null mice) |
| Dosage: | 0.5, 1, 1.5, 2, 3, 4, or 5 mg/kg |
| Administration: | Intraperitoneal injection |
| Result: | Normalized Hyperactivity Observed in Fmr1 KO2 mice. |